CDC/NIH Web Information Database

---

Last data update: Apr 18, 2025. (Total: 8777 Documents)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

All CDC NIH

Next

Records 1-30 (of 54 Records)

CDC/NIH Web Information
COVID-19 Vaccines Are Safe for People Receiving Cancer Immunotherapy NCI, November 2022
NIH Long COVID Computational Challenge (L3C): AI/ML models to predict susceptibility and likelihood of developing PASC/Long COVID NIH, October 2022
Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time NIH, July 19, 2022
NIH-funded project offers efficient approach when tracking SARS-CoV-2 variants NIH, June 2022
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac and ChAdOx1 and BNT162b2 plus heterologous BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults. S Niyomaitham et al, MEDRXIV, March 6, 2022
Input on Technologies and Approaches that can Identify Individuals Susceptible to Developing Post-Acute-Sequelae of SARS-CoV-2 infection (PASC) NIH, RFI, August 2021
NIH scientists develop faster COVID-19 test NIH, August 16, 2021
NIH launches study of third COVID-19 vaccine dose in kidney transplant recipients- Trial will assess antibody response in people who did not respond to two-dose regimen. NIH August 10, 2021
More Genetic Clues to COVID-19 Susceptibility and Severity F Collins, NIH Director's blog, July 21, 2021
Experimental vaccine protects against multiple coronaviruses NIH Research Matters, July 20, 2021
NIH study offers new evidence of early SARS-CoV-2 infections in U.S. NIH, June 15, 2021
COVID-19 Vaccines May Be Less Effective in Some People with Cancer NCI, May 27, 2021
CDC and NIH bring COVID-19 self-testing to residents in two locales- Participating households will receive free month-long supply of rapid tests aimed at reducing community transmission. NIH, March 31, 2021
COVIDcode Study: Learning more about the genetic contributions to the severity of the disease of COVID-19 NIH, January 2021
Phase 3 trial of Novavax investigational COVID-19 vaccine opens NIH, January 28, 2020
NIH funds eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in children Awards part of a larger effort to study pediatric COVID-19 and related conditions. NIH, December 21, 2020
NIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA Ellume USA’s rapid at-home test was developed through the NIH RADx Initiative. NIH News Release, December 15, 2020
Study Highlights Need for Continued Care of COVID-19 Survivors NIH Director's blog, October 2020
Face Coverings Could Save 130,000 American Lives from COVID-19 by March NIH Director's Blog, November 3 2020
Inviting Comments and Suggestions on the NIH-Wide Strategic Plan for COVID-19 Research NIH, October 2020
Rogue Antibodies and Gene Mutations Explain Some Cases of Severe COVID-19 F Collins, NIH Director's Blog, October 6, 2020
Genome Data Help to Track COVID-19 Superspreading Event NIH Director's blog, September 8, 2020
Study Ties COVID-19-Related Syndrome in Kids to Altered Immune System NIH Director's blog, September 1, 2020
People with intellectual and developmental disabilities disproportionately affected by COVID-19 NIH, August 28, 2020
Potent neutralizing antibodies target new regions of coronavirus spike NIH Research Matters, August 4, 2020
What We Know About COVID-19’s Effects on Child and Maternal Health NIH Director's Blog, July 31, 2020
Phase 3 clinical trial of investigational vaccine for COVID-19 begins NIH News, July 27, 2020
Placenta lacks major molecules used by SARS-CoV-2 virus to cause infection NIH News, July 14, 2020
Experimental COVID-19 vaccine safe, generates immune response- NIH-sponsored Phase 1 trial tested mRNA vaccine. NIH News, July 14, 2020
NIH-Wide Strategic Plan for COVID-19 Research NIH, July 13, 2020